低级别浆液性癌:加拿大实践模式与患者结局多中心回顾
该回顾性队列研究纳入5家加拿大转诊机构2000至2016年134例II-IV期低级别浆液性癌患者,中位随访32.4个月,比较四种主要治疗模式。新辅助化疗后手术者无进展生存更差;多因素分析显示较小残留病灶、较年轻年龄和原发腹膜来源与更好的总生存/无进展生存显著相关。复发后无进展间期和至下次治疗时间在不同治疗类型间无显著差异。
要点
- 加拿大各机构低级别浆液性癌治疗模式存在明显差异。
- 新辅助化疗后手术与更差的无进展生存相关。
- 较小残留病灶、较年轻年龄和原发腹膜来源与更好生存相关。
核心结论
- 加拿大低级别浆液性癌实践模式差异显著,需持续评估以优化患者结局。
- 新辅助化疗后手术者无进展生存更差。
- 复发后无进展间期和至下次治疗时间在不同治疗类型间无显著差异。
研究设计与样本
- 2000至2016年在5家加拿大转诊机构开展的回顾性队列研究。
- 纳入134例II-IV期低级别浆液性癌患者,中位随访32.4个月(范围1.6-228)。
- 数据收集和病理报告标准化,采用Cox回归分析临床和病理因素对结局与预后的影响。
主要发现
- 四种主要治疗模式:手术加化疗56%,新辅助化疗后手术27%,仅手术9%,手术加抗激素治疗4%。
- 81%患者使用以铂类/紫杉醇为主的初级化疗。
- 多因素Cox回归分析显示较小残留病灶、较年轻年龄和原发腹膜来源与更好的总生存/无进展生存显著相关(p < 0.03)。
- 一家机构的无进展生存显著优于其他机构(p = 0.025),可能与原发腹膜低级别浆液性癌比例更高有关。
临床怎么用
- 应关注低级别浆液性癌治疗模式的机构间差异,并推动标准化评估。
- 对新辅助化疗后手术患者需警惕更差的无进展生存。
- 残留病灶、年龄和原发部位可用于预后分层参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Patients with advanced low-grade serous carcinoma (LGSC) have poor long-term survival rates. As a rare histotype, there are uncertainties regarding the use of current therapies. Thus, we studied practice patterns and treatment outcomes as part of a national initiative to better understand and improve the care of women with advanced LGSC. METHODS: This retrospective cohort study was conducted in 5 Canadian referral institutions from 2000 to 2016. Data collection and pathology reporting were standardized. Outcome measures included overall survival (OS), progression-free survival (PFS), progression-free intervals (PFI), and time to next treatment (TTNT). Cox regression analysis was used to evaluate the effects of clinical and pathologic factors on outcomes and prognosis. RESULTS: There were 134 patients (stage II-IV) with a median follow-up of 32.4 months (range 1.6-228). Four primary treatments were compared across institutions: 1) surgery followed by chemotherapy (56%), 2) neoadjuvant chemotherapy (NACT) followed by surgery (27%), 3) surgery alone (9%), and 4) surgery followed by anti-hormone therapy (4%). Primary platinum/paclitaxel chemotherapy was used in 81%. Patients treated with NACT had worse PFS. Multivariable Cox regression analysis identified lesser residual disease, younger age, and primary peritoneal origin as variables significantly associated with better OS/PFS (p < 0.03). One institution had significantly better PFS than the others (p = 0.025), but this finding could be related to a higher frequency of primary peritoneal LGSC. PFI and TTNT intervals in patients with relapsed disease were not significantly different after the first relapse irrespective of treatment type. CONCLUSIONS: There are notable differences in practice patterns across Canada. This underscores the need for ongoing strategies to measure, evaluate and achieve optimal patient outcomes for women with advanced LGSC.
引用
- Scott SA, Llaurado Fernandez M, Kim H, et al. Low-grade serous carcinoma (LGSC): A Canadian multicenter review of practice patterns and patient outcomes. Gynecol Oncol. 2020. PMID: 32001076. doi:10.1016/j.ygyno.2020.01.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。